Pfizer Inc. closed 28.57% short of its 52-week high of $31.54, which the company reached on July 30th.

We recently published a list of 15 Recent Activist Investor Campaigns. In this article, we are going to take a look at where ...

Cantor Fitzgerald analyst Carter Gould initiated coverage with a Hold rating on Pfizer (PFE – Research Report) yesterday and set a price target ...

Cantor Fitzgerald analyst Carter Gould initiated coverage of Pfizer (PFE) with a Neutral rating and $24 price target Pfizer made “concrete ...

DelveInsight's "HEMLIBRA Market Size, Forecast, and Market Insight Report" highlights the details around HEMLIBRA, a ...

The pharmaceutical industry faces environmental challenges. Green chemistry offers sustainable solutions to reduce waste and ...